Andrea Pfeifer
Founder at AC IMMUNE SA
Net worth: 7 M $ as of 2024-03-30
Andrea Pfeifer active positions
Companies | Position | Start | End |
---|---|---|---|
AC IMMUNE SA | Director/Board Member | 2015-12-31 | - |
Chief Executive Officer | 2003-02-12 | - | |
Founder | 2003-02-12 | - | |
Investor Relations Contact | 2003-02-12 | - | |
SYMRISE AG | Director/Board Member | 2011-04-30 | - |
Independent Dir/Board Member | 2011-04-30 | - | |
University of Lausanne | Corporate Officer/Principal | - | - |
BioMedInvest AG I
BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Chairman | - | - |
AB2 Bio SA
AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Chairman | - | - |
Career history of Andrea Pfeifer
Former positions of Andrea Pfeifer
Companies | Position | Start | End |
---|---|---|---|
2INVEST AG | Director/Board Member | 2010-05-26 | 2012-10-17 |
Nestlé Nespresso SA
Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Nestlé Nespresso SA designs and manufactures espresso machines. The company was founded in 1986 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - | - |
Inventages II
Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Founder | - | - |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Chairman | 2002-08-28 | - |
░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Andrea Pfeifer
Wuerzburg Schweinfurt University of Applied Sciences | Doctorate Degree |
Statistics
International
Switzerland | 8 |
Germany | 4 |
United States | 2 |
Operational
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Chairman | 3 |
Sectoral
Finance | 5 |
Health Technology | 3 |
Process Industries | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
2INVEST AG | Finance |
AC IMMUNE SA | Health Technology |
SYMRISE AG | Process Industries |
Private companies | 6 |
---|---|
Nestlé USA, Inc.
Nestlé USA, Inc. Agricultural Commodities/MillingProcess Industries Nestle USA, Inc. produces dairy and bakery products. Its products include chocolate and confectionaries, beverages, ice cream, juices, milk products, pet food, prepared foods, and sports nutrition. The company is headquartered in Arlington, VA. | Process Industries |
BioMedInvest AG I
BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Finance |
Nestlé Nespresso SA
Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Nestlé Nespresso SA designs and manufactures espresso machines. The company was founded in 1986 and is headquartered in Zurich, Switzerland. | Producer Manufacturing |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Finance |
Inventages II
Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Finance |
AB2 Bio SA
AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Andrea Pfeifer
- Experience